Year archive

FIREBRICK PHARMA LIMITED — 2026 filings

All 39 regulatory filings released by FIREBRICK PHARMA LIMITED (FRE) in 2026, sourced directly from the official regulator.

39 Filings

2026 Period

2026 filings (39)

Filing	Released	Lang
Application for quotation of securities - FRE 7 pages 22.2KB Share Issue/Capital Change	2026-05-13	English
Options Range Report 1 Regulatory Filings	2026-05-13	English
Options Top 20 Holders Report 2 pages 70.7KB Regulatory Filings	2026-05-13	English
Nasodine patent accepted in Canada 1 Regulatory Filings	2026-05-12	English
Firebrick investor webinar update 1 page 142.2KB Regulatory Filings	2026-04-21	English
March 2026 Quarterly Activity Report & Appendix 4C 8 pages 305.9KB Interim / Quarterly Report Q3 2026	2026-04-20	English
Notification regarding unquoted securities - FRE 5 pages 16.9KB Share Issue/Capital Change	2026-04-19	English
Application for quotation of securities - FRE 6 pages 18.5KB Share Issue/Capital Change	2026-04-16	English
Notification regarding unquoted securities - FRE 6 pages 20.0KB Share Issue/Capital Change	2026-04-16	English
Notification regarding unquoted securities - FRE 5 pages 17.0KB Share Issue/Capital Change	2026-04-16	English
Cleansing Notice 2 pages 144.4KB Share Issue/Capital Change	2026-04-16	English
Change in substantial holding - Peter Molloy 3 pages 376.3KB Major Shareholding Notification	2026-04-16	English
Change in substantial holding - Stephen Goodall 3 pages 316.7KB Major Shareholding Notification	2026-04-16	English
Notification of cessation of securities - FRE 4 pages 14.8KB Regulatory Filings	2026-04-13	English
Application for quotation of securities - FRE 6 pages 18.4KB Regulatory Filings	2026-04-12	English
Application for quotation of securities - FRE 6 pages 18.5KB Regulatory Filings	2026-04-12	English
Notification regarding unquoted securities - FRE 5 pages 17.0KB Regulatory Filings	2026-04-12	English
Cleansing Notice 2 pages 144.8KB Regulatory Filings	2026-04-12	English
Firebrick Secures $1.5 million via Placement 4 pages 266.1KB Regulatory Filings	2026-03-30	English
Proposed issue of securities - FRE 6 pages 21.1KB Regulatory Filings	2026-03-30	English
Registration Agreement and Approval of Nasodine in Indonesia 2 pages 154.0KB Regulatory Filings	2026-03-26	English
Trading Halt 2 pages 226.8KB Regulatory Filings	2026-03-26	English
Firebrick to present at NWR Virtual Healthcare Conference 1 Regulatory Filings	2026-03-18	English
Nasodine patent accepted in the Philippines 1 page Regulatory Filings	2026-03-17	English
FRE appoints Head of Business Development and Licensing 2 pages 152.0KB Regulatory Filings	2026-03-16	English
Firebrick Investor Update Presentation 18 pages 2.8MB Regulatory Filings	2026-03-03	English
Initial Director's Interest Notice - Al Moghaddam 2 pages 265.8KB Regulatory Filings	2026-03-01	English
Appendix 4D & Half-Year Financial Report to 31 December 2025 24 pages 982.2KB Regulatory Filings	2026-02-23	English
Release of Securities from Voluntary Escrow 1 page Regulatory Filings	2026-02-18	English
Application for quotation of securities - FRE 6 pages 18.4KB Regulatory Filings	2026-02-12	English
Cleansing Notice 2 pages 144.9KB Regulatory Filings	2026-02-12	English
Proposed issue of securities - FRE 5 pages 17.2KB Regulatory Filings	2026-02-11	English
Notification regarding unquoted securities - FRE 6 pages 20.3KB Regulatory Filings	2026-02-10	English
Firebrick Appoints New Independent Director 5 pages 263.6KB Regulatory Filings	2026-02-09	English
Proposed issue of securities - FRE 5 pages 18.5KB Regulatory Filings	2026-02-09	English
December 2025 Quarterly Activity Report & Appendix 4C 9 pages 316.9KB Regulatory Filings	2026-01-27	English
Nasodine Throat Spray Product Launch in Fiji 1 page Regulatory Filings	2026-01-21	English
Nasodine Throat Spray Product Launch in Singapore 3 pages 230.1KB Regulatory Filings	2026-01-20	English
Update on Registration of Nasodine in the Philippines 2 pages 111.5KB Regulatory Filings	2026-01-11	English